Allele specific expression (ASE) analysis robustly measures cis regulatory effects. Here, we present a vast ASE resource generated from the GTEx v8 release, containing 15,253 samples spanning 54 human tissues for a total of 431 million measurements of ASE at the SNP-level and 153 million measurements at the haplotype-level. In addition, we developed an extension of our tool phASER that allows effect sizes of cis regulatory variants to be estimated using haplotypelevel ASE data. This ASE resource is the largest to date and we are able to make haplotype-level data publicly available. We anticipate that the availability of this resource will enable future studies of regulatory variation across human tissues.
the mapping bias that is sometimes present in ASE analysis, resulting in 4 data types per sample ( Fig. S1 , Methods -Data Generation). Across samples, this produced over 431 million measurements of ASE at the SNP-level and 153 million measurements of ASE at the haplotypelevel. To demonstrate the ability of these data to robustly capture cis-regulatory effects and also benchmark the four data types relative to one another, we estimated eQTL effect sizes from ASE data using allelic fold change (aFC) (Mohammadi, 2017) and compared them to those derived from eQTL mapping (GTEx Consortium, 2019) . To make it easier to generate aFC estimates for regulatory variants from phASER data, we developed a new add-on to the software package, phASER-POP, eliminating the need for custom scripts (Fig. S2 , Methods -Software). We found high correlations between ASE and eQTL estimates, with a median spearman rho of 0.80 across tissues for SNP-level ASE data, and 0.83 for haplotype-level data generated by phASER ( Fig.   1c ). Haplotype-level correlations were significantly higher than SNP-level correlations (p = 3.55e-15, Wilcoxon paired signed rank test) while at the same time producing estimates for a median of 20% more genes (Fig. S3 ). WASP correction significantly improved correlations for both SNP-(p = 2.49e-13) and haplotype-(p = 3.55e-15) level data, so we therefore recommend using WASPcorrected data for most downstream analyses.
In the GTEx RNA-seq data, at a minimum coverage of 8 reads, samples had a median of 7,607 genes with ASE data at the SNP-level and 10,043 genes at the haplotype-level, and this dropped as a function of increasing coverage thresholds ( Fig. S4 ). With the same coverage threshold, at the tissue level, there were a median of 18,042 genes with a median of 128 samples per gene using haplotype ASE data, rendering the data set well-powered to detect cis-regulatory effects ( Fig. 2a ). The median number of samples with ASE data per gene was largely dependent on tissue sample size, ranging from 39 for kidney (N = 73 samples) to 321 for thyroid (N = 574 samples). The number of genes with ASE data was determined by both sample size and gene expression diversity in tissues, with the two cell lines having the lowest number of genes with ASE data (LCLs = 15, 804, fibroblasts = 16, 526) and testis having the largest number of genes with ASE data (21,952) despite an intermediate sample size of 322.
Finally, we sought to demonstrate the pervasiveness of cis-regulatory effects that can be captured with this resource. We found that even strong regulatory effects, where one allele was expressed at > 2x the level of the other allele, are widely present, even for protein coding genes, with 47% of protein coding genes showing such an effect in at least one tissue and at least 50 individuals ( Fig S5) . Considering all genes, we found that a median of 10,183 genes (or a median of 56% of those genes with ASE data) per tissue exhibited significant allelic imbalance (binomial test, FDR < 5% at the gene-level) in at least one sample, indicating the wide-spread nature of cisregulatory effects (Fig. 2b ). Removing individuals that were heterozygous for any known GTEx eQTL (Methods -GTEx eQTLs) only resulted in a median reduction of 7.5% in the number of genes with significant imbalance in at least one sample, demonstrating the potential of this resource to identify additional, likely rare regulatory effects that are not captured in eQTL analysis.
A full summary of these statistics across tissues and sample thresholds is available in Table S1 .
Conclusion
In this work, we used the GTEx v8 release to produce a vast ASE resource, consisting of hundreds of millions of measurements of allelic expression. We generated SNP-and haplotypelevel data, which provides better estimates of allelic expression for a greater number of genes.
These data have numerous uses for the study of regulatory variation. For example, they have been used to replicate sex-, population-and cell type-specific eQTLs as well as capture the effects of rare regulatory variants (GTEx Consortium, 2019; Ferraro, 2019; Kim-Hellmuth, 2019) . By making haplotype-level ASE data publicly available for the first time, we anticipate that this resource will find similarly broad use as the eQTL data it complements. 
Methods

Data Generation and Availability
Paired-end 75bp Illumina RNA-seq reads were aligned to hg38 using STAR (Dobin, 2013) v2.5.3a (without allelic mapping bias correction) and v2.6.0c (with allelic mapping bias correction) in two-pass mode, and with allelic mapping bias correction enabled via the --waspOutputMode option which replicates the approach in van de Geijn et al., 2015 (the full settings of the alignment pipeline are described at https://github.com/broadinstitute/gtex-pipeline). All data was generated with or without using this feature and is indicated by "_WASP_" in the file names.
SNP-level ASE data was generated using the GATK ASEReadCounter tool v3.8-0-ge9d806836 with the following settings: -U ALLOW_N_CIGAR_READS -minDepth 1 --allow_potentially_misencoded_quality_scores --minMappingQuality 255 --minBaseQuality 10.
Raw SNP-level data, consisting of the GATK tool output, were aggregated per subject across all tissues. Raw autosomal SNP-level data, for SNPs with ≥8 reads, was annotated by: assigning heterozygous SNPs to genes using Gencode v26, calculating the expected null ratio for each combination of ref/alt allele (Castel, 2015) , calculating a binomial p-value by comparing to the expected null ratio, calculating a multiple hypothesis corrected p-value per tissue using Benjamini-Hochberg, and flagging sites that overlapped low-mappability regions (75-mer mappability <1 based on 75mer alignments with up to two mismatches), showed mapping bias in simulation (Panousis, 2014) , or had no more reads supporting two alleles than would be expected from sequencing noise alone, indicating potential genotyping errors (FDR < 1%, see Castel, 2015 for description of test). The genotype warning test cannot distinguish between strong allelic expression and a true genotyping error, and as a result should not be used when studying phenomena with expected mono-allelic expression (e.g. imprinting).
Haplotype-level data was generated using phASER v1.0.1 (Castel, 2016) . phASER was run using whole genome sequencing genotype calls that were population-phased with Shapeit v2.837 in read-backed phasing mode with whole genome sequencing reads (Delaneau, 2013) .
phASER was run using all available RNA-seq libraries per subject. RNA-seq read-backed phased genotype data are provided (filename: phASER_GTEx_v8_merged.vcf.gz). Haplotypic expression was calculated using phASER Gene AE 1.2.0 and Gencode v26 gene annotations with min_haplo_maf 0.01. Haplotypic expression matrices containing all samples were generated using the "phaser_expr_matrix.py" script. This consists of a single string per sample per gene with the format "HAP_A_COUNT|HAP_B_COUNT". One matrix was generated using only haplotypes that could be genome wide phased such that the haplotype assignment is consistent across genes within an individual and with the phased VCF (filename:
phASER_GTEx_v8_matrix.gw_phased.txt.gz). Another was generated that does not ensure genome wide haplotype phasing across genes, which includes more counts, but makes the haplotype assignment of A/B arbitrary and unrelated across genes within an individual or the VCF 
Software and Availability
The original phASER package produced gene-level haplotypic expression per individual (Castel, 2016) . We developed new additions to phASER (phASER-POP) that make it easier to analyze data across many samples, as is often done with gene expression quantifications. First, we developed a new addition to the software (phaser_expr_matrix.py) that enables the aggregation of gene-level haplotypic expression measurement files across samples to produce a single haplotypic expression matrix, where each row is a gene and each column is a sample. The values consist of a single string per sample per gene in the format "HAP_A_COUNT|HAP_B_COUNT". This format is intended to facilitate downstream analyses of allelic expression.
Second, we developed a tool to make it easier to estimate effect sizes of regulatory variants using phASER haplotypic expression data (phaser_cis_var.py). As input, this script takes a phASER haplotype expression matrix, a VCF, and a list of variants to calculate effect sizes for.
To improve accuracy, the read-backed phased VCFs produced by phASER should be used, but first need to be combined across individuals, which can be performed using, e.g., "bcftools merge ind1.vcf.gz ind2.vcf.gz …". The tool phases variant alleles with haplotype expression data and outputs numerous statistics, including allelic fold change (aFC, Mohammadi, 2017) per sample, and a median across samples for individuals that heterozygous for the variant of interest. This median can be used as the estimate of the regulatory variant effect size. The output also includes statistics calculated for homozygous individuals, which can be used to test for increased allelic imbalance in heterozygotes as compared to homozygotes, as would be expected for true regulatory variants.
The software along with extensive documentation is available through GitHub (http://www.github.com/secastel/phaser).
GTEx eQTLs
For comparison between eQTL effect size and allelic expression effect size, GTEx v8 top significant (FDR < 5%) eQTLs were used from 49 tissues (GTEx Consortium, 2019) . This results in at most a single eQTL per gene in a given tissue. When quantifying the number of samples that are not heterozygous for a known eQTL but still show allelic imbalance, gene-level haplotypic expression levels were excluded for a sample if the individual was heterozygous for a top significant eQTL or a nominally significant (permutation p < 1e-4) independent eQTL in any of the 49 tissues.
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